TaylorDPatonCKapurS. Maudsley prescribing guidelines, 11th ed. West Sussex: Wiley-Blackwell, 2012, pp. 201–217.
4.
MooreMMing YuenHDunnM. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ2009; 339: b3999–b3999.
5.
LeydenGRodgersLKendrickT. A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract2007; 24: 570–575.
JohnsLCvan OsJ. The continuity of psychotic experiences in the general population. Clin Psychol Rev2001; 21: 1125–1141.
8.
WoodsSWTullyEMWalshBC. Aripiprazole in the treatment of the psychosis prodrome: an open label pilot study. Br J Psychiatry Suppl2007; 51: 96–101.
9.
TaylorDPatonCKapurS. Maudsley prescribing guidelines, 11th ed. West Sussex: Wiley-Blackwell, 2012, pp. 126–142.
10.
AxelsonDFindlingRLFristadMA. Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry2012; 73: 1342–1350.
DoeyTHandelmanKSeabrookJA. Survey of atypical antipsychotic prescribing by Canadian child psychiatrists and developmental pediatricians for patients aged under 18 years. Can J Psychiatry2007; 52: 363–368.
13.
JamesAC. Prescribing antipsychotics for children and adolescents. Adv Psychiatric Tr2010; 16: 63–75.
Angermeyer M, Matschinger H and Schomerus G. Attitudes towards psychiatric treatment and people with mental illness: changes over two decades. B J Psychiatry August 2013; 203: 146–51.
16.
Evans-LackoSBrohanEMojtabaiR. Association between public views of mental illness and self-stigma among individuals with mental illness in 14 European countries. Psychol Med2012; 42: 1741–1752.
SchomerusGSchwahnCHolzingerA. Evolution of public attitudes about mental illness: a systematic review and meta-analysis. Acta Psychiatr Scand2012; 125: 440–452.
21.
CorkerEHamiltonSHendersonC. Experiences of discrimination among people using mental health services in England 2008-2011. Br J Psychiatry Suppl2013; 55: 58–63.
LuxtonDDJuneJDComtoisKA. Can postdischarge follow-up contacts prevent suicide and suicidal behavior? A review of the evidence. Crisis2013; 34: 32–41.
34.
HorwitzAWakefieldJ. All we have to fear: psychiatry's transformation of natural anxieties into mental disorders, New York: Oxford University Press, 2012.
35.
MoynihanRDoustJHenryD. Preventing overdiagnosis: how to stop harming the healthy. BMJ2012; 344: e3502–e3502.
36.
Clarkson C, Keating H and Cunningham S. Clarkson and Keating criminal law: texts and materials (6th ed.). London: Sweet & Maxwell, 2007.
37.
LoughnanA. Manifest madness: mental capacity in criminal law, Oxford: Oxford University Press, April 2010.
38.
SlovenkoRJ. The DSM in litigation and legislation. J Am Acad Psychiatry Law2011; 39: 6–11.
39.
AhmedARankinEFranceC. The reliability of psychiatric diagnosis revisited. Clin Guide Improve Reliability Psychiatric Diagn Psychiatry2006; 3: 41–50.
40.
HassDRadeletF. Could the American Psychiatric Association cause you headaches? the interaction between the DSM-5 and employment law. Loyola Univ Chicago Law J, ▪▪, 2013, pp. 683–683.
FrancesA. The forensic risks of DSM-V and how to avoid them. J Am Acad Psychiatry Law2010; 38: 11–14.
43.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing, 2013.
44.
WortzelH. The DSM-5 and forensic psychiatry. J Psychiatr Pract2013; 19: 238–241.